AIM ImmunoTech, Inc. (AIM)

1.04 -0.01 (-0.95%) USD  |  NYAM  |  Feb 23, 16:00
1.04 0.00 (0.00%) After-Hours: 19:59
More

AIM ImmunoTech Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
LadRx Corp. Upgrade
Plus Therapeutics, Inc. Upgrade